Zobrazeno 1 - 10
of 11
pro vyhledávání: '"L Cucic"'
Autor:
L Savic-Spasic, N Arnautovic, J Vratonjic, L Cucic, D Trifunovic Zamaklar, V Sulovic, I Mrdovic, M Asanin, S Aleksandric, Gordana Krljanac
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 22
Funding Acknowledgements Type of funding sources: None. onbehalf PREDICT-VT Heart failure (HF) still develops in 4% up to 28% of STEMI pts treated by pPCI, with the highest incidence in the first year. Accurate and early identification of high-risk p
Autor:
I Mrdovic, L Cucic, M Asanin, L Savic-Spasic, J Vratonjic, N Arnautovic, V Sulovic, S Aleksandric, Gordana Krljanac, D Trifunovic Zamaklar
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 22
Funding Acknowledgements Type of funding sources: None. onbehalf PREDICT-VT More extensive coronary atherosclerosis in diabetes mellitu (DM) induces poorer clinical outcomes after STEMI, but there are data suggesting that impaired myocardial function
Autor:
M Vorkapic, M Asanin, N Arnautovic, I Mrdovic, S Aleksandric, L Cucic, L Savic-Spasic, D Trifunovic Zamaklar, J Vratonjic, Gordana Krljanac
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 22
Funding Acknowledgements Type of funding sources: None. onbehalf PREDICT-VT In spite of contemporary STEMI management, heart failure (HF) develops in 4% up to 28% of pPCI-treated patients, with the highest incidence in the first year. Left ventricula
Autor:
Gordana Krljanac, Danijela Trifunovic, V Sulovic, I Mrdovic, S Aleksandric, J Dudic, L Cucic, M Asanin, L Savic-Spasic
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 21
Prognosis after STEMI is still challenging. One-year mortality ranges between 10-12% and the incidence of heart failure (HF) is between 4% and 28%. Early and accurate identification of high-risk patients necessitates therapy intensification. Aim this
Autor:
S Aleksandric, Danijela Trifunovic, J Dudic, L Cucic, M Asanin, I Mrdovic, V Sulovic, L Savic-Spasic, Gordana Krljanac
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 21
Data regarding heart failure (HF) development among patients with preserved EF (≥50%) after STEMI are spare. Accurate and early identification of patients at risk might allow timely application of modern therapy targeted for HFpEF. Aim the current
Autor:
S Aleksandric, Danijela Trifunovic, Milika Asanin, L Savic Spasic, J Dudic, Gordana Krljanac, L Cucic, Igor Mrdovic, Sulovic
Publikováno v:
European Heart Journal. 40
Background Malignant ventricular arrhythmias in STEMI patients carry ominous prognosis including sudden cardiac death (SCD). According to the current guidelines only EF Aim To define whether quantification of myocardial mechanics early after pPCI usi
Autor:
Gordana Krljanac, L Cucic, Milika Asanin, J Dudic, Sulovic, Danijela Trifunovic, S Aleksandric, L Savic Spasic, Igor Mrdovic
Publikováno v:
European Heart Journal. 40
Background Predicting malignant ventricular and sudden cardiac death (SCD) in STEMI patients with middle-range and preserved EF is challenge. Aim To identify the best parameters to predict composite end-point defined as secondary VF, sustained/non-su
Autor:
S Aleksandric, Danijela Trifunovic, Igor Mrdovic, J Dudic, Gordana Krljanac, L Cucic, Milika Asanin, L Savic-Spasic, V Sulovic
Publikováno v:
European Heart Journal. 40
Heart failure (HF) development after myocardial infarction with ST segment elevation (STEMI) in the modern era varies greatly (between 4% and 28%), with the highest incidence in the first year. Since, HF still carries substantial morbidity and mortal
Autor:
M Vorkapic, Gordana Krljanac, J Dudic, L Cucic, Milika Asanin, S Aleksandric, Lidija Savic, Danijela Trifunovic, Igor Mrdovic
Publikováno v:
European Heart Journal. 39
Autor:
Danijela Trifunovic, Milika Asanin, S Aleksandric, Lidija Savic, Igor Mrdovic, L Cucic, J Dudic, M Vorkapic, Gordana Krljanac
Publikováno v:
European Heart Journal. 39